Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-cd9895bd7-p9bg8 Total loading time: 0 Render date: 2024-12-26T03:21:22.041Z Has data issue: false hasContentIssue false

Disorders of the Anterior Horn Cell

from Part II - Neuromuscular Cases

Published online by Cambridge University Press:  29 November 2024

Jessica E. Hoogendijk ,
Marianne de Visser ,
Pieter A. van Doorn  and
Erik H. Niks
Jessica E. Hoogendijk
Affiliation:
University Medical Center Utrecht
Marianne de Visser
Affiliation:
Amsterdam University Medical Center
Pieter A. van Doorn
Affiliation:
Erasmus MC, University Medical Center, Rotterdam
Erik H. Niks
Affiliation:
Leiden University Medical Center
Get access
Type
Chapter
Information
Neuromuscular Disease
A Case-Based Approach
 , pp. 71 - 92
Publisher: Cambridge University Press
Print publication year: 2024

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Suggested Reading

Chiò, A, Moglia, C, Canosa, A, et al. Association of copresence of pathogenic variants related to amyotrophic lateral sclerosis and prognosis. Neurology 2023;101(1):e83–e93. doi: 10.1212/WNL.0000000000207367. Epub 2023 May 18. PMID: 37202167; PMCID: PMC10351316.CrossRefGoogle ScholarPubMed
Dharmadasa, T, Scaber, J, Edmond, E, et al. Genetic testing in motor neurone disease. Pract Neurol 2022;22(2):107–116. doi: 10.1136/practneurol-2021-002989. Epub 2022 Jan 13. PMID: 35027459; PMCID: PMC8938673.CrossRefGoogle ScholarPubMed
van Es, MA, Hardiman, O, Chio, A, et al. Amyotrophic lateral sclerosis. Lancet 2017;390(10107):2084–2098. doi: 10.1016/S0140-6736(17)31287-4. Epub 2017 May 25. PMID: 28552366.CrossRefGoogle ScholarPubMed
Govaarts, R, Beeldman, E, Kampelmacher, MJ, et al. The frontotemporal syndrome of ALS is associated with poor survival. J Neurol 2016;263(12):2476–2483. doi: 10.1007/s00415-016-8290-1. Epub 2016 Sep 26. PMID: 27671483; PMCID: PMC5110703.CrossRefGoogle ScholarPubMed
Van Damme, P, Al-Chalabi A, Andersen PM, Chiò A, Couratier P, De Carvalho M, Hardiman O, Kuźma-Kozakiewicz M, Ludolph A, McDermott CJ, Mora JS, Petri S, Probyn K, Reviers E, Salachas F, Silani V, Tysnes OB, van den Berg LH, Villanueva G, Weber M. European Academy of Neurology (EAN) guideline on the management of amyotrophic lateral sclerosis in collaboration with European Reference Network for Neuromuscular Diseases (ERN EURO-NMD). Eur J Neurol. 2024 Jun;31(6):e16264. doi: 10.1111/ene.16264. Epub 2024 Mar 12. PMID: 38470068.CrossRefGoogle Scholar
Oliver, D, Radunovic, A, Allen, A, McDermott, C. The development of the UK National Institute of Health and Care Excellence evidence-based clinical guidelines on motor neurone disease. Amyotroph Lateral Scler Frontotemporal Degener 2017;18 (5-6):313–323. doi: 10.1080/21678421.2017.1304558. Epub 2017 May 17. PMID: 28513234.CrossRefGoogle ScholarPubMed
Shefner, JM, Al-Chalabi, A, Baker, MR, et al. A proposal for new diagnostic criteria for ALS. Clin Neurophysiol 2020;131(8):1975–1978. doi: 10.1016/j.clinph.2020.04.005. Epub 2020 Apr 19. PMID: 32387049.CrossRefGoogle ScholarPubMed

Suggested Reading

Hassan, A, Mittal, SO, Hu, WT, et al. Natural history of ‘pure’ primary lateral sclerosis. Neurology 2021;96(17):e2231–e2238. doi: 10.1212/WNL.0000000000011771. Epub 2021 Feb 26. PMID: 33637635; PMCID: PMC8166429.CrossRefGoogle ScholarPubMed
Schito, P, Russo, T, Domi, T, et al. Clinical features and biomarkers to differentiate primary and amyotrophic lateral sclerosis in patients with an upper motor neuron syndrome. Neurology 2023;101(8):352–356CrossRefGoogle ScholarPubMed
Shribman, S, Reid, E, Crosby, AH, Houlden, H, Warner, TT. Hereditary spastic paraplegia: from diagnosis to emerging therapeutic approaches. Lancet Neurol 2019;18(12):1136–1146. doi: 10.1016/S1474-4422(19)30235-2. Epub 2019 Jul 31. PMID: 31377012.CrossRefGoogle ScholarPubMed
Turner, MR, Barohn, RJ, Corcia, P, et al.; Delegates of the 2nd International PLS Conference; Mitsumoto, H. Primary lateral sclerosis: consensus diagnostic criteria. J Neurol Neurosurg Psychiatry 2020;91(4):373–377. doi: 10.1136/jnnp-2019-322541. Epub 2020 Feb 6. PMID: 32029539; PMCID: PMC7147236.CrossRefGoogle ScholarPubMed

Suggested Reading

Kim, WK, Liu, X, Sandner, J, et al. Study of 962 patients indicates progressive muscular atrophy is a form of ALS. Neurology 2009;73(20):1686–1692. doi: 10.1212/WNL.0b013e3181c1dea3. PMID: 19917992; PMCID: PMC2788803.CrossRefGoogle ScholarPubMed
Liewluck, T, Saperstein, DS. Progressive muscular atrophy. Neurol Clin 2015;33(4):761–773. doi: 10.1016/j.ncl.2015.07.005. PMID: 26515620.CrossRefGoogle ScholarPubMed
Pugdahl, K, Camdessanché, JP, Cengiz, B, et al. Gold Coast diagnostic criteria increase sensitivity in amyotrophic lateral sclerosis. Clin Neurophysiol 2021;132(12):3183–3189. doi: 10.1016/j.clinph.2021.08.014. Epub 2021 Sep 8. PMID: 34544646.CrossRefGoogle ScholarPubMed
Wijesekera, LC, Mathers, S, Talman, P, et al. Natural history and clinical features of the flail arm and flail leg ALS variants. Neurology 2009;72(12):1087–1094. doi: 10.1212/01.wnl.0000345041.83406.a2. PMID: 19307543; PMCID: PMC2821838.CrossRefGoogle ScholarPubMed

Suggested Reading

Lay, S, Gudlavalleti, A, Sharma, S. Hirayama disease. In StatPearls [Internet]. Treasure Island, FL: StatPearls Publishing; 2023 Jan–. PMID: 29763088.Google Scholar

Suggested Reading

Breza, M, Koutsis, G. Kennedy’s disease (spinal and bulbar muscular atrophy): a clinically oriented review of a rare disease. J Neurol 2019;266(3):565–573. doi: 10.1007/s00415-018-8968-7. Epub 2018 Jul 13. PMID: 30006721.CrossRefGoogle ScholarPubMed
Hashizume, A, Fischbeck, KH, Pennuto, M, Fratta, P, Katsuno, M. Disease mechanism, biomarker and therapeutics for spinal and bulbar muscular atrophy (SBMA). J Neurol Neurosurg Psychiatry 2020;91(10):1085–1091. doi: 10.1136/jnnp-2020-322949. PMID: 32934110.CrossRefGoogle ScholarPubMed
Pradat, PF, Bernard, E, Corcia, P, et al.; French Kennedy’s Disease Writing Group. The French national protocol for Kennedy’s disease (SBMA): consensus diagnostic and management recommendations. Orphanet J Rare Dis 2020;15(1):90. doi: 10.1186/s13023-020-01366-z. PMID: 32276665; PMCID: PMC7149864.CrossRefGoogle ScholarPubMed

Suggested Reading

Baranello, G, Darras, BT, Day, JW, et al.; FIREFISH Working Group. Risdiplam in type 1 spinal muscular atrophy. N Engl J Med 2021;384(10):915–923. doi: 10.1056/NEJMoa2009965. Epub 2021 Feb 24. PMID: 33626251.CrossRefGoogle ScholarPubMed
Finkel, RS, Mercuri, E, Darras, BT, et al.; ENDEAR Study Group. Nusinersen versus sham control in infantile-onset spinal muscular atrophy. N Engl J Med 2017;377(18):1723–1732. doi: 10.1056/NEJMoa1702752. PMID: 29091570.CrossRefGoogle ScholarPubMed
Finkel, RS, Mercuri, E, Meyer, OH, et al.; SMA Care Group. Diagnosis and management of spinal muscular atrophy: part 2: pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethics. Neuromuscul Disord 2018;28(3):197–207. doi: 10.1016/j.nmd.2017.11.004. Epub 2017 Nov 23. PMID: 29305137.CrossRefGoogle ScholarPubMed
Kirschner, J, Butoianu, N, Goemans, N, et al. European ad-hoc consensus statement on gene replacement therapy for spinal muscular atrophy. Eur J Paediatr Neurol 2020;28:38–43. doi: 10.1016/j.ejpn.2020.07.001. Epub 2020 Jul 9. PMID: 32763124; PMCID: PMC7347351.CrossRefGoogle ScholarPubMed
Mendell, JR, Al-Zaidy, S, Shell, R, et al. Single-dose gene-replacement therapy for spinal muscular atrophy. N Engl J Med 2017;377(18):1713–1722. doi: 10.1056/NEJMoa1706198. PMID: 29091557.CrossRefGoogle ScholarPubMed
Mercuri, E, Finkel, RS, Muntoni, F, et al.; SMA Care Group. Diagnosis and management of spinal muscular atrophy: part 1: recommendations for diagnosis, rehabilitation, orthopedic and nutritional care. Neuromuscul Disord 2018;28(2):103–115. doi: 10.1016/j.nmd.2017.11.005. Epub 2017 Nov 23. PMID: 29290580.CrossRefGoogle ScholarPubMed

Suggested Reading

Mercuri, E, Finkel, RS, Muntoni, F, et al.; SMA Care Group. Diagnosis and management of spinal muscular atrophy: part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care. Neuromuscul Disord 2018;28(2):103–115. doi: 10.1016/j.nmd.2017.11.005. Epub 2017 Nov 23. PMID: 29290580.CrossRefGoogle ScholarPubMed
Mercuri, E, Darras, BT, Chiriboga, CA, et al.; CHERISH Study Group. Nusinersen versus sham control in later-onset spinal muscular atrophy. N Engl J Med 2018;378(7):625–635. doi: 10.1056/NEJMoa1710504. PMID: 29443664.CrossRefGoogle ScholarPubMed
Oskoui, M, Day, JW, Deconinck, N, et al.; SUNFISH Working Group. Two-year efficacy and safety of risdiplam in patients with type 2 or non-ambulant type 3 spinal muscular atrophy (SMA). J Neurol 2023;270(5):2531–2546. doi: 10.1007/s00415-023-11560-1. Epub 2023 Feb 3. Erratum in: J Neurol. 2023 Apr 18;: PMID: 36735057; PMCID: PMC9897618.CrossRefGoogle ScholarPubMed
Stam, M, Wijngaarde, CA, Bartels, B, et al. Randomized double-blind placebo-controlled crossover trial with pyridostigmine in spinal muscular atrophy types 2-4. Brain Commun 2022;5(1):fcac324. doi: 10.1093/braincomms/fcac324. PMID: 36632180; PMCID: PMC9825780.CrossRefGoogle ScholarPubMed
Wijngaarde, CA, Stam, M, Otto, LAM, et al. Muscle strength and motor function in adolescents and adults with spinal muscular atrophy. Neurology 2020;95(14):e1988–e1998. doi: 10.1212/WNL.0000000000010540. Epub 2020 Jul 30. PMID: 32732299.CrossRefGoogle ScholarPubMed

Suggested Reading

Koopman, FS, Beelen, A, Gilhus, NE, de Visser, M, Nollet, F. Treatment for postpolio syndrome. Cochrane Database Syst Rev 2015;(5):CD007818. doi: 10.1002/14651858.CD007818.pub3. PMID: 25984923.Google Scholar
Li Hi, Shing S, Chipika, RH, Finegan, E, et al. Post-polio syndrome: more than just a lower motor neuron disease. Front Neurol 2019;10:773. doi: 10.3389/fneur.2019.00773. PMID: 31379723; PMCID: PMC6646725.CrossRefGoogle Scholar
Murphy, OC, Messacar, K, Benson, L, et al.; AFM working group. Acute flaccid myelitis: cause, diagnosis, and management. Lancet 2021;397(10271):334–346. doi: 10.1016/S0140-6736(20)32723-9. Epub 2020 Dec 23. PMID: 33357469; PMCID: PMC7909727.CrossRefGoogle ScholarPubMed
Patel, H, Sander, B, Nelder, MP. Long-term sequelae of West Nile virus-related illness: a systematic review. Lancet Infect Dis 2015;15(8):951–959. doi: 10.1016/S1473-3099(15)00134-6. Epub 2015 Jul 7. PMID: 26163373.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×